Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Prevention of Cardiac Implantable Electronic Device Infections: Update and Evaluation of the Potential Role for Capsulectomy or the Antibiotic Pouch.

Gleva MJ, Poole JE.

J Atr Fibrillation. 2017 Feb 28;9(5):1540. doi: 10.4022/jafib.1540. eCollection 2017 Feb-Mar. Review.

2.

Effect of pocket irrigation with antimicrobial on prevention of pacemaker pocket infection: a meta-analysis.

Kang FG, Liu PJ, Liang LY, Lin YQ, Xie SL, He Y, Liang BS, Zhang HF, Chen YX, Wang JF.

BMC Cardiovasc Disord. 2017 Sep 30;17(1):256. doi: 10.1186/s12872-017-0689-9.

3.

Periprocedural Antibiotic Prophylaxis for Cardiac Implantable Electrical Device Procedures: Results From a Heart Rhythm Society Survey.

Basil A, Lubitz SA, Noseworthy PA, Reynolds MR, Gold H, Yassa D, Kramer D.

JACC Clin Electrophysiol. 2017 Jun;3(6):632-634. doi: 10.1016/j.jacep.2017.01.013. No abstract available.

4.

A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.

Ali S, Kanjwal Y, Bruhl SR, Alo M, Taleb M, Ali SS, Kabour A, Khawaja O.

Ther Adv Infect Dis. 2017 May;4(3):75-82. doi: 10.1177/2049936117702317. Epub 2017 May 1.

5.

Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.

Hosseini SM, Moazzami K, Rozen G, Vaid J, Saleh A, Heist KE, Vangel M, Ruskin JN.

Eur Heart J. 2017 Jul 14;38(27):2122-2128. doi: 10.1093/eurheartj/ehx100.

PMID:
28329322
6.

Microbiological Characteristics and Clinical Features of Cardiac Implantable Electronic Device Infections at a Tertiary Hospital in China.

Wang R, Li X, Wang Q, Zhang Y, Wang H.

Front Microbiol. 2017 Mar 6;8:360. doi: 10.3389/fmicb.2017.00360. eCollection 2017. Erratum in: Front Microbiol. 2017 May 19;8:928.

7.

Management of Cardiac Electronic Device Infections: Challenges and Outcomes.

Kirkfeldt RE, Johansen JB, Nielsen JC.

Arrhythm Electrophysiol Rev. 2016;5(3):183-187. doi: 10.15420/aer.2016:21:2.

8.

Incidence of Bleeding-Related Complications During Primary Implantation and Replacement of Cardiac Implantable Electronic Devices.

Nichols CI, Vose JG.

J Am Heart Assoc. 2017 Jan 22;6(1). pii: e004263. doi: 10.1161/JAHA.116.004263.

9.

Identifying the predictors of hematoma after device implantation: Closing in on the suspects with an aim to prevent the menace?

Bhargava K.

Indian Pacing Electrophysiol J. 2016 Sep - Oct;16(5):157-158. doi: 10.1016/j.ipej.2016.11.011. Epub 2016 Dec 1. No abstract available.

10.

Lead extractions in patients with cardiac implantable electronic device infections: Single center experience.

Goya M, Nagashima M, Hiroshima K, Hayashi K, Makihara Y, Fukunaga M, An Y, Ohe M, Yamazato S, Sonoda K, Yamashita K, Katayama K, Ito T, Niu H, Ando K, Yokoi H, Iwabuchi M.

J Arrhythm. 2016 Aug;32(4):308-12. doi: 10.1016/j.joa.2016.02.004. Epub 2016 Mar 22.

11.

Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey.

Nakajima H, Taki M.

J Arrhythm. 2016 Aug;32(4):303-7. doi: 10.1016/j.joa.2015.09.006. Epub 2015 Nov 4.

12.

New horizon for infection prevention technology and implantable device.

Kondo Y, Ueda M, Kobayashi Y, Schwab JO.

J Arrhythm. 2016 Aug;32(4):297-302. doi: 10.1016/j.joa.2016.02.007. Epub 2016 Mar 19. Review.

13.

Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement.

Imai K.

J Arrhythm. 2016 Aug;32(4):283-6. doi: 10.1016/j.joa.2015.06.007. Epub 2015 Aug 8. Review.

14.

Cardiac Implantable Electronic Device Infection in Patients at Risk.

Tarakji KG, Ellis CR, Defaye P, Kennergren C.

Arrhythm Electrophysiol Rev. 2016 May;5(1):65-71. doi: 10.15420/aer.2015.27.2.

15.

How Long Should Prophylactic Antibiotics be Prescribed for Permanent Pacemaker Implantations? One Day versus Three Days.

Chiang KH, Chao TF, Lee WS, Lin YJ, Tuan TC, Kong CW.

Acta Cardiol Sin. 2013 Jul;29(4):341-6.

16.

Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients.

Kennergren C.

Arrhythm Electrophysiol Rev. 2015 May;4(1):53-7. doi: 10.15420/aer.2015.4.1.53. Epub 2015 Apr 10.

17.

Management of Cardiac Implantable Electronic Device Infection.

Podoleanu C, Deharo JC.

Arrhythm Electrophysiol Rev. 2014 Nov;3(3):184-9. doi: 10.15420/aer.2014.3.3.184. Epub 2014 Nov 29.

18.

Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.

Kolek MJ, Patel NJ, Clair WK, Whalen SP, Rottman JN, Kanagasundram A, Shen ST, Saavedra PJ, Estrada JC, Abraham RL, Ellis CR.

J Cardiovasc Electrophysiol. 2015 Oct;26(10):1111-6. doi: 10.1111/jce.12768. Epub 2015 Sep 6.

19.

Mortality in patients on renal replacement therapy and permanent cardiac pacemakers.

Vanerio G, García C, González C, Ferreiro A.

Int J Nephrol. 2014;2014:284172. doi: 10.1155/2014/284172. Epub 2014 May 26.

20.

Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection.

Stavrakis AI, Niska JA, Shahbazian JH, Loftin AH, Ramos RI, Billi F, Francis KP, Otto M, Bernthal NM, Uslan DZ, Miller LS.

Antimicrob Agents Chemother. 2014;58(4):2377-86. doi: 10.1128/AAC.01943-13. Epub 2014 Feb 10.

Supplemental Content

Support Center